Novartis AG
NYSE:NVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
NYSE:NVS
|
CH |
|
Midpoint Holdings Ltd
XTSX:MPT
|
UK |
|
First National Financial Corp
TSX:FN
|
CA |
|
United States Steel Corp
NYSE:X
|
US |
|
V
|
VKTR Teknologi Mobilitas Tbk PT
IDX:VKTR
|
ID |
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
KR |
|
Diamondback Energy Inc
NASDAQ:FANG
|
US |
|
M
|
Mahindra and Mahindra Ltd
NSE:M&M
|
IN |
|
Generac Holdings Inc
NYSE:GNRC
|
US |
|
Palo Alto Networks Inc
BMV:PANW
|
US |
|
B
|
Bermaz Auto Bhd
KLSE:BAUTO
|
MY |
Wall St Price Targets
NVS Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NVS is 160.14 USD with a low forecast of 122.66 USD and a high forecast of 187.92 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NVS's stock price target?
Price Target
160.14
USD
According to Wall Street analysts, the average 1-year price target for NVS is 160.14 USD with a low forecast of 122.66 USD and a high forecast of 187.92 USD.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 4%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 5%.
